Celastrol could protect against TAA-induced hepatic fibrosis, including histology, decrease AST and ALT activities, proinflammatory factor expression and hepatic fibrosis gene and protein expression, and serum and liver metabolites (Supplementary Figs. 13a–f, 14e). This evidence concerns the gene GPT and Hepatic fibrosis.